arrow
O

Oriol Sibila

institut dinvestigacions biomèdiques august pi i sunyer
H指数:47
被引数:8,954

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

European Respiratory Society clinical practice guideline for the management of adult bronchiectasis

Chalmers, J.D.; Haworth, C.S.; Flume, P.; Long, M.B.; Burgel, P.R.; Dimakou, K.; Blasi, F.; Herrero-Cortina, B.; Dhar, R.; Chotirmall, S.H.; 等. 欧洲呼吸学会成人支气管扩张管理临床实践指南. Eur. Respir. J. 2025; 2501126, online ahead of print. [Google Scholar] [CrossRef]

2025-12-0122
PRE
OAS1 and OAS3 genetic variants enhance inflammatory responses to SARS-CoV-2

OAS1和OAS3基因变异增强了SARS-CoV-2的炎症反应

2025-11-110
OAAI
Investigating the impact of dipeptidyl peptidase-1 inhibition in humans using multi-omics

探究二肽基肽酶-1抑制在人类中的影响:多组学方法的应用

2025-08-060
OAAI
Persistence of dysfunctional immune response 12 months after SARS-CoV-2 infection and their relationship with pulmonary sequelae and long COVID

SARS-CoV-2感染12个月后的异常免疫反应持续存在及其与肺部后遗症和长期COVID的关系

2025-04-170
OA
Effect of N-Acetylcysteine on Bronchiectasis in a Real-life Study. Data From the Spanish RIBRON Registry

N-乙酰半胱氨酸对支气管扩张的影响:一项真实世界研究。数据来自西班牙RIBRON登记系统

2025-04-010
PRE
Persistent Blood Eosinophilia and Eosinopenia: Relationship with Outcomes in Bronchiectasis

持续性外周血嗜酸性粒细胞增多与减少:与支气管扩张预后的关系

2025-02-040
PRE
The Gut-Airways Microbiome axis in COPD
2024-10-300
PRE
Sputum Azurocidin-1 is a marker of disease severity and microbiome dysbiosis in adult bronchiectasis, and increases in response to Rhinovirus challenge in COPD.
2024-10-300
PRE
Geographic variation of the microbiome-resistome in bronchiectasis: Data from the European Bronchiectasis Registry (EMBARC)
2024-10-300
PRE
RCT Abstract - Inhaled colistimethate sodium in patients with bronchiectasis and Pseudomonas aeruginosa infection: Results of two randomized double-blind placebo-controlled phase 3 trials assessing safety and efficacy over 12 months
2024-10-300
PRE